Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

BESIVANCE

BESIFLOXACIN HYDROCHLORIDE

Standard Dose
EQ 0.6% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BESIVANCE is listed in Drugs@FDA under application 022308 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BESIFLOXACIN HYDROCHLORIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.6% BASE Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2018-04-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview BESIVANCE is listed in Drugs@FDA under application 022308 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BESIFLOXACIN HYDROCHLORIDE Form and strength SUSPENSION/DROPS;OPHTHALMIC - EQ 0.6% BASE Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2018-04-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.